Vertex Pharmaceuticals PE Ratio 2006-2018 | VRTX

Current and historical p/e ratio for Vertex Pharmaceuticals (VRTX) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Vertex Pharmaceuticals PE ratio as of January 16, 2019 is 83.34.
Vertex Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-01-16 186.15 74.46
2018-09-30 192.74 $2.50 77.10
2018-06-30 169.96 $1.59 106.89
2018-03-31 162.98 $0.86 189.51
2017-12-31 149.86 $1.04 144.10
2017-09-30 152.04 $0.78 194.92
2017-06-30 128.87 $1.02 126.34
2017-03-31 109.35 $0.69 158.48
2016-12-31 73.67 $-0.47 0.00
2016-09-30 87.21 $-0.91 0.00
2016-06-30 86.02 $-1.13 0.00
2016-03-31 79.49 $-1.65 0.00
2015-12-31 125.83 $-2.31 0.00
2015-09-30 104.14 $-2.74 0.00
2015-06-30 123.48 $-3.07 0.00
2015-03-31 117.97 $-2.97 0.00
2014-12-31 118.80 $-3.14 0.00
2014-09-30 112.31 $-2.21 0.00
2014-06-30 94.68 $-2.03 0.00
2014-03-31 70.72 $-1.61 0.00
2013-12-31 74.30 $-2.04 0.00
2013-09-30 75.82 $-2.58 0.00
2013-06-30 80.06 $-2.31 0.00
2013-03-31 54.97 $-2.36 0.00
2012-12-31 41.90 $-0.50 0.00
2012-09-30 55.89 $0.59 94.73
2012-06-30 55.92 $1.88 29.74
2012-03-31 41.01 $1.34 30.60
2011-12-31 33.21 $0.04 830.25
2011-09-30 44.46 $-1.60 0.00
2011-06-30 51.99 $-3.66 0.00
2011-03-31 47.93 $-3.81 0.00
2010-12-31 35.03 $-3.77 0.00
2010-09-30 34.57 $-3.72 0.00
2010-06-30 32.90 $-3.52 0.00
2010-03-31 40.87 $-3.51 0.00
2009-12-31 42.85 $-3.72 0.00
2009-09-30 37.90 $-3.83 0.00
2009-06-30 35.97 $-3.92 0.00
2009-03-31 28.73 $-3.59 0.00
2008-12-31 30.38 $-3.27 0.00
2008-09-30 33.24 $-2.97 0.00
2008-06-30 33.47 $-2.86 0.00
2008-03-31 23.89 $-3.11 0.00
2007-12-31 23.23 $-3.03 0.00
2007-09-30 38.41 $-2.59 0.00
2007-06-30 28.56 $-2.23 0.00
2007-03-31 28.04 $-2.04 0.00
2006-12-31 37.42 $-1.87 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $47.708B $2.489B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $127.049B 14.36
Gilead Sciences (GILD) United States $88.639B 10.67
Biogen (BIIB) United States $68.008B 13.77
Celgene (CELG) United States $61.695B 11.97
Illumina (ILMN) United States $44.906B 52.31
Regeneron Pharmaceuticals (REGN) United States $43.827B 22.20
Alexion Pharmaceuticals (ALXN) United States $24.927B 17.06
BioMarin Pharmaceutical (BMRN) United States $16.903B 0.00
Incyte (INCY) United States $16.761B 463.29
Seattle Genetics (SGEN) United States $11.532B 0.00
Exact Sciences (EXAS) United States $9.474B 0.00
BeiGene (BGNE) Cayman Islands $8.545B 0.00
QIAGEN (QGEN) Netherlands $8.278B 26.47
Alnylam Pharmaceuticals (ALNY) United States $8.140B 0.00
Sarepta Therapeutics (SRPT) United States $7.934B 0.00
Exelixis (EXEL) United States $7.191B 20.38
Bluebird Bio (BLUE) United States $6.601B 0.00
Bio-Techne Corp (TECH) United States $5.997B 40.51
Moderna (MRNA) United States $5.457B 0.00
Amarin (AMRN) Ireland $5.283B 0.00
Galapagos (GLPG) Belgium $5.277B 0.00
Alkermes (ALKS) Ireland $5.134B 3304.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.759B 0.00
Horizon Pharma Public (HZNP) Ireland $3.713B 15.28
Array BioPharma (ARRY) United States $3.688B 0.00
Guardant Health (GH) United States $3.437B 0.00
Immunomedics (IMMU) United States $3.432B 0.00
Allogene Therapeutics (ALLO) United States $3.395B 0.00
ARGENX SE-ADR (ARGX) Netherlands $3.344B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.323B 0.00
Emergent Biosolutions (EBS) United States $3.298B 27.78
Ascendis Pharma (ASND) Denmark $3.141B 0.00
Blueprint Medicines (BPMC) United States $2.903B 0.00
Ligand Pharmaceuticals (LGND) United States $2.801B 21.43
Akcea Therapeutics (AKCA) United States $2.735B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.668B 0.00
China Biologic Products (CBPO) China $2.665B 18.97
Ultragenyx Pharmaceutical (RARE) United States $2.590B 0.00
Genomic Health (GHDX) United States $2.520B 85.07
Global Blood Therapeutics (GBT) United States $2.442B 0.00
Repligen (RGEN) United States $2.423B 75.67
Halozyme Therapeutics (HALO) United States $2.313B 51.61
Amicus Therapeutics (FOLD) United States $2.270B 0.00
Myriad Genetics (MYGN) United States $2.194B 21.73
Reata Pharmaceuticals (RETA) United States $2.163B 0.00
Arena Pharmaceuticals (ARNA) United States $2.161B 0.00
Mirati Therapeutics (MRTX) United States $2.107B 0.00
Acceleron Pharma (XLRN) United States $2.029B 0.00
Denali Therapeutics (DNLI) United States $1.994B 0.00
Innoviva (INVA) United States $1.943B 10.99
AnaptysBio (ANAB) United States $1.888B 0.00
MyoKardia (MYOK) United States $1.853B 0.00
Allakos (ALLK) United States $1.837B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.837B 0.00
Insmed (INSM) United States $1.800B 0.00
Atara Biotherapeutics (ATRA) United States $1.658B 0.00
Spark Therapeutics (ONCE) United States $1.613B 0.00
REGENXBIO (RGNX) United States $1.573B 21.10
Vanda Pharmaceuticals (VNDA) United States $1.536B 122.04
Zai Lab Unsponsored ADR (ZLAB) China $1.495B 0.00
Medicines (MDCO) United States $1.465B 0.00
Cambrex (CBM) United States $1.435B 10.71
NeoGenomics (NEO) United States $1.423B 117.15
Biohaven Pharmaceutical Holding (BHVN) United States $1.409B 0.00
Aimmune Therapeutics (AIMT) United States $1.394B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.299B 0.00
WAVE Life Sciences (WVE) Singapore $1.275B 0.00
Editas Medicine (EDIT) United States $1.262B 0.00
Myovant Sciences (MYOV) United Kingdom $1.249B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.241B 0.00
Clovis Oncology (CLVS) United States $1.229B 0.00
UniQure (QURE) Netherlands $1.182B 0.00
Rubius Therapeutics (RUBY) United States $1.169B 0.00
Lion Biotechnologies (IOVA) United States $1.160B 0.00
Sangamo Therapeutics (SGMO) United States $1.157B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.123B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.093B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.090B 0.00
Fate Therapeutics (FATE) United States $1.056B 0.00
Solid Biosciences (SLDB) United States $1.055B 0.00
Audentes Therapeutics (BOLD) United States $1.054B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.002B 0.00
Retrophin (RTRX) United States $0.964B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.947B 0.00
Puma Biotechnology (PBYI) United States $0.923B 0.00
Apellis Pharmaceuticals (APLS) United States $0.835B 0.00
Coherus BioSciences (CHRS) United States $0.829B 0.00
InflaRx (IFRX) Germany $0.826B 0.00
Novavax (NVAX) United States $0.812B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.805B 0.00
Acorda Therapeutics (ACOR) United States $0.788B 9.98
Alder BioPharmaceuticals (ALDR) United States $0.784B 0.00
Epizyme (EPZM) United States $0.776B 0.00
AC Immune SA (ACIU) Switzerland $0.769B 0.00
Vericel (VCEL) United States $0.768B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.768B 0.00
Athenex (ATNX) United States $0.767B 0.00
CytomX Therapeutics (CTMX) United States $0.764B 0.00
Dynavax Technologies (DVAX) United States $0.755B 0.00
Revance Therapeutics (RVNC) United States $0.747B 0.00
Principia Biopharma (PRNB) United States $0.739B 0.00
G1 THERAPEUTICS (GTHX) United States $0.734B 0.00
Intra-Cellular Therapies (ITCI) United States $0.725B 0.00
Cellectis (CLLS) France $0.695B 0.00
UNITY Biotechnology (UBX) $0.695B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.693B 0.00
UROGEN PHARMA (URGN) Israel $0.693B 0.00
Heska (HSKA) United States $0.686B 56.15
Dicerna Pharmaceuticals (DRNA) United States $0.682B 0.00
Kura Oncology (KURA) United States $0.642B 0.00
RA PHARMCTL INC (RARX) United States $0.635B 0.00
ANI Pharmaceuticals (ANIP) United States $0.630B 12.06
Twist Bioscience (TWST) United States $0.629B 0.00
Intellia Therapeutics (NTLA) United States $0.619B 0.00
Viking Therapeutics (VKTX) United States $0.609B 0.00
Aptinyx (APTX) United States $0.597B 0.00
Cara Therapeutics (CARA) United States $0.597B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.585B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.572B 0.00
Arvinas (ARVN) United States $0.521B 0.00
Zymeworks (ZYME) Canada $0.517B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.502B 0.00
ObsEva SA (OBSV) Switzerland $0.501B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.500B 0.00
Anika Therapeutics (ANIK) United States $0.484B 20.05
Gritstone Oncology (GRTS) United States $0.482B 0.00
Prothena (PRTA) Ireland $0.480B 0.00
Eidos Therapeutics (EIDX) United States $0.476B 0.00
DBV Technologies (DBVT) France $0.471B 0.00
Osiris Therapeutics (OSIR) United States $0.466B 0.00
PDL BioPharma (PDLI) United States $0.461B 7.52
Kezar Life Sciences (KZR) United States $0.454B 0.00
Inovio Pharmaceuticals (INO) United States $0.451B 0.00
Mesoblast (MESO) Australia $0.443B 0.00
Arcus Biosciences (RCUS) United States $0.436B 0.00
BeyondSpring (BYSI) United States $0.422B 0.00
Evelo Biosciences (EVLO) United States $0.422B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.415B 0.00
Scholar Rock Holding (SRRK) United States $0.413B 0.00
MediciNova (MNOV) United States $0.405B 0.00
Synthorx (THOR) United States $0.404B 0.00
Senesco Technologies (ELOX) United States $0.400B 0.00
Zealand Pharma (ZEAL) Denmark $0.400B 4.41
Cytokineticsorporated (CYTK) United States $0.384B 0.00
Kindred Biosciences (KIN) United States $0.379B 0.00
Agenus (AGEN) United States $0.377B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.372B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Krystal Biotech (KRYS) United States $0.365B 0.00
Five Prime Therapeutics (FPRX) United States $0.363B 0.00
Abeona Therapeutics (ABEO) United States $0.346B 0.00
AVROBIO (AVRO) United States $0.343B 0.00
Replimune (REPL) United States $0.333B 0.00
Cellular Biomedicine (CBMG) United States $0.332B 0.00
Stemline Therapeutics (STML) United States $0.316B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.310B 0.00
Kodiak Sciences (KOD) United States $0.309B 0.00
Merus (MRUS) Netherlands $0.308B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.302B 0.00
MeiraGTx Holdings (MGTX) United States $0.302B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.301B 0.00
BioDelivery Sciences (BDSI) United States $0.293B 0.00
Albireo Pharma (ALBO) United States $0.290B 0.00
Enochian Biosciences (ENOB) United States $0.289B 0.00
Sorrento Therapeutics (SRNE) United States $0.278B 0.00
Urovant Sciences (UROV) United States $0.275B 0.00
Kadmon Holdings (KDMN) United States $0.275B 0.00
Intec Pharma (NTEC) Israel $0.269B 0.00
Gamida Cell (GMDA) Israel $0.257B 0.00
Verastem (VSTM) United States $0.254B 0.00
Seres Therapeutics (MCRB) United States $0.253B 0.00
Liquidia Technologies (LQDA) United States $0.251B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.249B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.243B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.239B 0.00
Axsome Therapeutics (AXSM) United States $0.237B 0.00
Celcuity (CELC) United States $0.236B 0.00
Strongbridge Biopharma (SBBP) United States $0.230B 0.00
ResTORbio (TORC) United States $0.227B 0.00
Aduro Biotech (ADRO) United States $0.226B 0.00
PSivida (EYPT) United States $0.224B 0.00
Magenta Therapeutics (MGTA) United States $0.222B 0.00
MannKind (MNKD) United States $0.220B 0.00
Celyad SA (CYAD) Belgium $0.216B 0.00
Kamada (KMDA) Israel $0.215B 19.74
Syros Pharmaceuticals (SYRS) United States $0.213B 0.00
Kala Pharmaceuticals (KALA) United States $0.211B 0.00
Adverum Biotechnologies (ADVM) United States $0.210B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.208B 0.00
Arbutus Biopharma (ABUS) Canada $0.206B 0.00
Athersys (ATHX) United States $0.206B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.205B 0.00
CorMedix Inc (CRMD) United States $0.199B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.195B 0.00
Geron (GERN) United States $0.194B 0.00
XBiotech (XBIT) United States $0.194B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
LogicBio Therapeutics (LOGC) United States $0.187B 0.00
Equillium (EQ) United States $0.184B 0.00
Synlogic (SYBX) United States $0.183B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.181B 0.00
Protagonist Therapeutics (PTGX) United States $0.178B 0.00
TOCAGEN INC (TOCA) United States $0.178B 0.00
Cerecor (CERC) United States $0.176B 0.00
Allena Pharmaceuticals (ALNA) United States $0.171B 0.00
Cohbar (CWBR) United States $0.169B 0.00
VBI Vaccines (VBIV) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.158B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
Constellation Pharmaceuticals (CNST) United States $0.155B 0.00
Enzo Biochem (ENZ) United States $0.154B 0.00
ADMA Biologics Inc (ADMA) United States $0.150B 0.00
Compugen (CGEN) Israel $0.148B 0.00
Unum Therapeutics (UMRX) United States $0.148B 0.00
Motif Bio Plc (MTFB) United States $0.146B 0.00
Palatin Technologies (PTN) United States $0.144B 17.74
BioTime (BTX) United States $0.142B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.140B 0.00
Spero Therapeutics (SPRO) United States $0.140B 0.00
Checkpoint Therapeutics (CKPT) United States $0.135B 0.00
Axovant Sciences (AXON) United Kingdom $0.132B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.125B 0.00
Pluristem Therapeutics (PSTI) Israel $0.125B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.122B 0.00
Cocrystal Pharma (COCP) United States $0.120B 133.33
XOMA (XOMA) United States $0.119B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.117B 0.00
Proteostasis Therapeutics (PTI) United States $0.116B 0.00
OvaScience (MLND) United States $0.114B 0.00
Cue Biopharma (CUE) United States $0.113B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.110B 0.00
NantKwest (NK) United States $0.108B 0.00
ETON PHARMACEUT (ETON) United States $0.107B 0.00
Signal Genetics (MGEN) United States $0.103B 0.00
Neothetics (EVFM) United States $0.102B 0.00
VTv Therapeutics (VTVT) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.097B 0.00
Mersana Therapeutics (MRSN) United States $0.092B 0.00
PHASEBIO PHARMA (PHAS) United States $0.090B 0.00
Mustang Bio (MBIO) United States $0.088B 0.00
TIZIANA LIFE SC (TLSA) United Kingdom $0.085B 0.00
Anavex Life Sciences (AVXL) United States $0.085B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.085B 0.00
Chiasma (CHMA) United States $0.085B 0.00
Cidara Therapeutics (CDTX) United States $0.085B 0.00
Aptose Biosciences (APTO) Canada $0.085B 0.00
Cel-Sci (CVM) United States $0.084B 0.00
BioXcel Therapeutics (BTAI) United States $0.082B 0.00
OVID THERAPEUTC (OVID) United States $0.082B 0.00
VolitionRX (VNRX) Singapore $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 0.00
ITUS (ANIX) United States $0.077B 0.00
Provention Bio (PRVB) United States $0.074B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.073B 0.00
Fortress Biotech (FBIO) United States $0.073B 0.00
ScPharmaceuticals (SCPH) United States $0.072B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.071B 0.00
AEterna Zentaris (AEZS) United States $0.066B 12.50
Merrimack Pharmaceuticals (MACK) United States $0.064B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.062B 0.00
Eleven Biotherapeutics (SESN) United States $0.061B 0.00
Alimera Sciences (ALIM) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Ophthotech (OPHT) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.057B 0.00
Monster Digital (INNT) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.057B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Alcobra (ARCT) United States $0.055B 0.00
Adial Pharmaceuticals (ADIL) United States $0.055B 0.00
Bellerophon Therapeutics (BLPH) United States $0.054B 0.00
Evogene (EVGN) Israel $0.054B 0.00
VistaGen Therapeutics (VTGN) United States $0.053B 0.00
Selecta Biosciences (SELB) United States $0.051B 0.00
Vaccinex (VCNX) United States $0.050B 0.00
Caladrius Biosciences (CLBS) United States $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Proteon Therapeutics (PRTO) United States $0.047B 0.00
Arsanis (ASNS) United States $0.047B 0.00
Celldex Therapeutics (CLDX) United States $0.045B 0.00
Bionano Genomics (BNGO) United States $0.045B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.045B 0.00
Versartis (ARAV) United States $0.044B 3.86
OncoSec Medical (ONCS) United States $0.044B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
Trevena (TRVN) United States $0.042B 0.00
Asterias Biotherapeutics (AST) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.041B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
Moleculin Biotech (MBRX) United States $0.039B 0.00
Celsion (CLSN) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
Leap Therapeutics (LPTX) United States $0.037B 0.00
Oncolytics Biotech (ONCY) Canada $0.036B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Clearside Biomedical (CLSD) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.035B 0.00
Galena Biopharma (SLS) United States $0.034B 0.00
Curis (CRIS) United States $0.033B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.032B 0.00
Sophiris Bio (SPHS) United States $0.032B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.031B 0.00
Oragenics (OGEN) United States $0.029B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.029B 4.75
Zosano Pharma (ZSAN) United States $0.028B 0.00
Eyenovia (EYEN) United States $0.027B 0.00
IMMURON LTD (IMRN) Australia $0.027B 0.00
TRACON Pharmaceuticals (TCON) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.025B 0.00
BioPharmX (BPMX) United States $0.025B 0.00
GENPREX INC (GNPX) United States $0.024B 0.00
GTx (GTXI) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.021B 0.00
Vical (VICL) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
IBio (IBIO) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Aileron Therapeutics (ALRN) United States $0.017B 0.00
Soligenix (SNGX) United States $0.016B 0.00
Advaxis (ADXS) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Benitec Biopharma (BNTC) Australia $0.015B 0.00
Cellect Biotechnology (APOP) Israel $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Therapix Biosciences (TRPX) Israel $0.013B 6.61
Genetic Technologies (GENE) Australia $0.013B 0.00
Pulmatrix (PULM) United States $0.013B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
Vital Therapies (VTL) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.010B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Aytu Bioscience (AYTU) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.008B 0.00
RestorGenex (DFFN) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Neuralstem (CUR) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00